Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis - MPR
Links shared publicly online about this topic.
- 104total visits
Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis - MPR
empr.com —
View full resource at empr.com
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, FDA, Orencia, Bristol-Myers Squibb, News
Most Recently Shared on August 1, 2011 at 2:49 pm By:
MPR News: Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis: The FDA has approved a subcutan... http://bit.ly/njnX58
Abatacept Approved for Sub-Q Injection - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A formulation of the rheumatoid arthritis drug abatacept (Orencia) that patients can self-inject subcutaneously has received FDA approval, its manufacturer said.” View full resource at qualitypointtech.net
Most Recently Shared on August 2, 2011 at 4:45 pm By:
Abatacept Approved for Sub-Q Injection: (MedPage Today) -- A formulation of the rheumatoid arthritis drug abatacep... http://bit.ly/p7hlfY
Medical News: Abatacept Approved for Sub-Q Injection - in Rheumatology, Arthritis from MedPage Today
medpagetoday.com — “A formulation of the rheumatoid arthritis drug abatacept (Orencia) that patients can self-inject subcutaneously has received FDA approval, its manufacturer said.” View full resource at medpagetoday.com
Most Recently Shared on August 2, 2011 at 4:17 pm By:
Patricia Grace Eldercare Expert
Abatacept Approved for Sub-Q Injection: (MedPage Today) -- A formulation of the rheumatoid arthritis drug abatac... http://bit.ly/nVm7Ck
Medical News: Abatacept Approved for Sub-Q Injection - in Rheumatology, Arthritis from MedPage Today
medpagetoday.com — “A formulation of the rheumatoid arthritis drug abatacept (Orencia) that patients can self-inject subcutaneously has received FDA approval, its manufacturer said.” View full resource at medpagetoday.com
Most Recently Shared on August 2, 2011 at 4:16 pm By:
Abatacept Approved for Sub-Q Injection http://bit.ly/rkVdpL
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
drugs.com — “Orencia (abatacept) is used for the treatment of rheumatoid arthritis. Information from Drugs.com includes Orencia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 2, 2011 at 12:27 am By:
FDA Approves Subcutaneous Formulation of Orencia - http://bit.ly/pjN8oc
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
drugs.com — “Orencia (abatacept) is used for the treatment of rheumatoid arthritis. Information from Drugs.com includes Orencia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 2, 2011 at 12:14 am By:
Drugs and Devices OW OW Health
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-A... http://bit.ly/qnjY9u #drug
UPDATE 1-Bristol-Myers gets FDA ok for subcutaneous Orencia | Reuters
reuters.com — “* Drug will be commercially available in the US in Sept. July 29 (Reuters) - Biopharmaceutical company Bristol-MyersSquibb Co said the U.S. Food and Drug Administrationapproved a subcutaneous” View full resource at reuters.com
Most Recently Shared on July 30, 2011 at 1:34 pm By:
Drugs and Devices OW OW Health
Bristol-Myers gets FDA ok for subcutaneous Orencia - Reuters: RTT NewsBristol-Myers gets FDA ok for subcut... http://bit.ly/qiLwaG #drug
Medical News: ACR: Injectable Abatacept as Good as IV Therapy - in Meeting Coverage, ACR from MedPage Today
medpagetoday.com — “ATLANTA -- A new version of the rheumatoid arthritis drug abatacept (Orencia) that can be given by subcutaneous injection performed as well as the current intravenous formulation, according to data pr” View full resource at medpagetoday.com
Most Recently Shared on November 13, 2010 at 2:02 pm By:
ACR: Injectable Abatacept as Good as IV Therapy (CME/CE): ATLANTA (MedPage Today) -- A new version of the rheuma... http://bit.ly/cEk0R1
ACR: Injectable Abatacept as Good as IV Therapy (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “ATLANTA (MedPage Today) -- A new version of the rheumatoid arthritis drug abatacept (Orencia) that can be given by subcutaneous injection performed as well as the current intravenous formulation, according to data presented here.” View full resource at qualitypointtech.net
Most Recently Shared on November 12, 2010 at 3:27 pm By:
ACR: Injectable Abatacept as Good as IV Therapy (CME/CE): ATLANTA (MedPage Today) -- A new version of the rheumato... http://bit.ly/cuEJav
Advertisement
